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Abstract 
Ofloxacin  is a synthetic chemotherapeutic antibiotic used for treatment of a 
variety of bacterial infections, but therapy suffers from low patients’ compliance 
due to its unpleasant taste. This study was aimed to develop taste masked 
microspheres of ofloxacin using Eudragit and to prepare orodispersible tablets 
of the formulated microspheres using natural superdisintegrant. Taste masking 
Eudragit E100 microspheres were prepared by solvent evaporation technique 
with an entrapment efficiency ranging from 69.54 ± 1.98 to 86.52 ± 2.25%. DSC 
revealed no interaction between the drug and polymer. Microspheres prepared 
at a drug/polymer ratio of 1:4 and 1:5 revealed sufficient flow properties and 
better taste masking as compared to other ratios. Drug loaded microspheres 
were formulated as orodispersible tablets using locust bean gum as a natural 
superdisintegrant offering the advatages of biocompatibility and biodegrad-
ability. The wetting time, water absorption ratio and in-vitro disintegration time of 
the tablets were found to range between 19 ± 2 to 10 ± 3 seconds, 59.11 ± 0.65 
to 85.76 ± 0.96 and 22 ± 2 to 10 ± 2 seconds, respectively. The in-vitro 
ofloxacin release was about 97.25% within 2h. The results obtained from the 
study suggested the use of eudragit polymer for preparing ofloxacin loaded 
microspheres with an aim to mask the bitter taste of the drug and furthermore 
orodispersible tablets could be formulated using locust bean gum as a natural 
superdisintegrant.  
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Introduction 
Any medication which imparts an unpleasant taste is likely to result in poor patient 
compliance to a drug regimen especially for the children and elderly. Taste is a sensory 
response resulting from  a chemical stimulation of taste buds on the tongue. Taste 
transduction is the process through which sense of taste is directed to the brain [1]. In 
general four different types of taste are there including sweet, sour, bitter and salty 
corresponding to which four different types of taste receptors are there. Sweet taste is 
mostly detected at the tip of the tongue, bitter taste at the back and the salty taste is 
sensed at the sides of the tongue [2]. Taste is detected when the soluble substances react 
with taste receptors and the perception of taste is transmitted to the brain via ninth cranial 
nerve. Various techniques to eliminate bitter taste of drugs include use of flavours [3], 
polymeric coatings [4], complexation with ion exchange resins [5], complexation with 
cyclodextrins [6], microencapsulation [7], chemical modifications etc. Microencapsulation is 
a process in which very thin coatings are applied around particles (solid/liquid). Therefore 
a microsphere is a small sphere having uniform coating around it, which provides it many 
useful properties like taste masking, controlled release etc. There diameter usually falls in 
a range of 1 μm  to  1000 μm.  Microspheres  can  be  prepared  by  variety  of  methods 
including air suspension, coacervation phase separation, spray drying and congealing, pan 
coating, solvent evaporation and multiorifice centrifugation techniques [8]. Micro 
particulated entrapment of bitter drugs in the matrix of pH sensitive reverse enteric coated 
polymer, without compromising dissolution and bioavailability of drugs, were prepared by 
different methods has been reported in US Patent 20050136114 [9]. Eudragit E100 is a 
polymethacrylate with pH dependent solubility, specifically used for taste masking. It is 
soluble in gastric fluid up to pH 5.0 and is swellable and permeable above pH 5.0 [10]. So 
when the microencapsulated drug is consumed, it does not interact with taste receptors as 
it is insoluble in mouth. The moment the microencapsulated drug reaches the stomach the 
acidic pH conditions favour dissolution and thus the drug is released. Thus 
microencapsulation is a useful technique for masking the unpleasant taste. The most 
convenient method for preparation of microspheres is solvent evaporation technique. This 
technique is easier to perform in laboratory conditions [11]. Over other techniques it offers 
advantages like it does not use elevated temperatures like spray drying method thus 
suitable for thermo labile compounds. Control of particle size is easier in solvent 
evaporation method as compared to other methods. 
The oral route of drug delivery is the most preferred route of administration of drugs for 
systemic action. Tablets are most widely used oral dosage forms as it provides 
advantages like ease of administration, transportability, compactness, non-invasive, easy 
to manufacture and contains a single accurate dosage of drug. In case of conventional 
tablets bed ridden, children and old age patients often face swallowing problems leading to 
poor patient compliance. To overcome these problems fast disintegrating tablets also 
known as orodispersible tablets are prepared which when placed on tongue disintegrates 
within seconds and the drug dissolves or get dispersed in saliva [12]. As no water is 
needed to administer these tablets, these offer an advantage of any time medicine for 
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orodispersible tablets include lyophilization [13], moulding [14], direct compression [15], 
cotton candy process [16], spray drying [17], sublimation [18] and nanonization [19]. These 
techniques are based on the principles of increasing porosity and/or addition of 
superdisintegrants and water soluble excipients in the tablets [20].  
Plant products nowadays are widely used as a substitute to synthetic products due to ease 
of local availability, lower prices as compared to synthetic products, biocompatible, 
biodegradable and environment friendly nature. Locust bean gum also called as carob 
bean gum is a galactomannan vegetable gum extracted from the seeds of the Carob tree 
(Ceretonia siliqua), mostly found in the Mediterranean regions. Locust bean gum has been 
widely used in food industry as a thickening and gelling agent [21]. Recently it has been 
established as a potential superdisintegrant in orodispersible tablets [22]. Owing to 
extensive swelling properties and superdisintegrant action of locust bean gum, it was used 
as superdisintegrant in orodispersible tablets containing taste masked microspheres of 
ofloxacin.  
Ofloxacin is a synthetic fluorinated carboxyquinolone that has a broad spectrum of activity 
against both gram-negative and gram-positive bacteria [23]. It acts on DNA gyrase, an 
enzyme which like human topoisomerase, prevents the supercoiling of DNA during 
replication or transcription. Chemically, ofloxacin is a racemate, (±)-9-fluoro-3-methyl-10-
(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic 
acid. The usual dose of ofloxacin tablets is 200 mg to 400 mg orally every 12 h. The 
purpose of the present study was to formulate orodispersible tablets containing taste 
masked microspheres of ofloxacin by utilising a natural superdisintegrant (locust bean 
gum). The orodispersible tablets were evaluated for evaluated for parametric tests 
(thickness, diameter, hardness, tensile strength and friability), wetting time, water 
absorption ratio, effective pore radius, porosity, packing fraction, moisture uptake studies, 
in-vitro and in-vivo disintegration time, in-vitro release and stability studies. 
Experimental 
Materials  
Ofloxacin was received as gift samples from Park Pharmaceuticals, Baddi, India. Eudragit 
E-100 was obtained as gift sample from Panacea Biotec, Lalru, India. Locust bean gum 
was obtained as gift sample from Lucid Colloids, Mumbai, India. Avicel PH-101(Batch No: 
RB13764) was procured from Sigma Aldrich, USA. Talc (Batch No: G635309) and 
magnesium stearate (Batch No: LB205509) were purchased from Loba Chemie, Mumbai, 
India. Hydrochloric acid (Batch No: 88893) and n-Hexane (Batch No: LB252809) were 
obtained from Thomas Baker and Loba Chemie, Mumbai, India respectively. All other 
chemicals and reagents were of analytical grade and were used as such. 
Preparation of Microspheres 
Microspheres were prepared using solvent evaporation method. Firstly, Eudragit E100 was 
dissolved in mixture of organic solvent, ethanol: dichloromethane (8:2) on a magnetic 
stirrer (Eltek Instruments, MS 2012, India) to obtain uniform mixing. To this mixture, 
magnesium stearate (5% w/v) was added which served as droplet stabilizer followed by 
addition of ofloxacin with continuous stirring. The drug-polymer ratio was taken as 1:1, 1:2, 
1:4 and 1:5. The polymer drug solution was added dropwise into a mixture of light liquid 656  K. Malik, G. Arora, and I. Singh:   
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paraffin and n-Hexane containing Span 80 (2% w/v) maintained at 40 ºC. After complete 
evaporation of the solvent the microspheres were allowed to settle,  supernatant was 
decanted and the microspheres were recovered by filtration through a Whatman filter 
paper (No. 41) followed by washing thoroughly with n-Hexane. The microspheres were 
dried at room temperature in a desiccator and stored in desiccator till further use.  
Evaluation of microspheres 
Percentage yield determination 
The prepared microspheres were completely dried in an oven maintained at 37°C for 24 h 
and then weighed. The percentage yield was calculated by the following formula:  
% Yield = 
Weight of microspheres 
Total weight of solid material 
× 100 
Entrapment efficiency 
The entrapment efficiency was calculated by the formula 
EE = 
Practical drug content
Theoretical drug content
× 100 
Entrapment efficiency was calculated by digesting outer layer of 20 mg microspheres in 10 
ml Chloroform and then 100 ml 0.1 N HCl was added. The suspension was then warmed 
for a few minutes, filtered & 1 ml of filtrate was made up to 10 ml with 0.1 N HCl. The 
solution was analysed using UV spectrophotometer (Systronics 2202) at 294 nm to 
determine amount of ofloxacin entrapped in microspheres. The calculations were made in 
triplicate. 
Evaluation of flow properties of microspheres 
The prepared microspheres were evaluated for flow properties including bulk density, 
tapped density, angle of repose, carr’s compressibility index and hausner ratio. 
Particle size evaluation 
Size distribution and average particle size of microspheres was calculated with optical 
microscopy. Optical microscope was fitted with eye piece micrometer which was then 
calibrated with a stage micrometer. Size of about 100 microspheres was calculated from 
each batch and then the average size was calculated.  
Morphology 
The morphology of the prepared batches of microspheres was evaluated by scanning 
electron microscopy (Hitachi S-520). Samples were mounted on aluminium stubs and 
coated with gold using a vacuum evaporator. Samples were then examined with a SEM 
microscope at an accelerating voltage of 10 kV. 
Compatibility studies 
Chemical interaction between the drug and the polymeric material, if any, during the 
preparation of the microspheres was studied by Differential Scanning Calorimetry (DSC).   Taste Masked Microspheres of Ofloxacin: Formulation and Evaluation of Orodispersible Tablets  657 
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DSC was carried out with the help of DSC equipment (DSC821e Mettler Toledo) calibrated 
using indium as a standard with a melting point (Tfus) of 156.63°C and a calibration energy 
Δfus of 28.89 J/g. The temperature was increased from 25°C to 300°C at a heating rate of 
10°C/min under a flow of nitrogen (80 ml/min).  
In-vitro taste evaluation of microspheres 
Microspheres equivalent to 100 mg ofloxacin were placed in volumetric flask with 25ml of 
pH 6.8 phosphate buffer (simulated saliva) and were stirred for 5 min. the resulting mixture 
was filtered and analysed using UV-Visible spectrophotometer (Systronics 2202) at 
294 nm.  
In-vivo taste evaluation of microspheres 
A protocol for conducting taste assessment by taste panel studies was accepted by the 
Institutional Ethical Committee of Chitkara University  (CU/CCP/MPh/2011/07). The 
prepared microspheres were subjected to taste evaluation test in 5 healthy male volun-
teers. All the volunteers were given details about the purpose, any risk involved and the 
procedure for taste evaluation. Taste evaluation of ofloxacin microspheres was conducted 
and the degree of bitterness was judged as per the five point scale given in table 1.  
Tab. 1.   Five point scale for taste evaluation 
Taste Characteristics  Score 
Pleasant  0 
Tasteless  1 
Slightly bitter  2 
Moderately bitter  3 
Intensely bitter  4 
 
Characterization of locust bean gum 
Locust bean gum was characterized for swelling index, loss on drying (LOD), viscosity, pH 
and for microbial load. Microbial load was determined as outlined in Indian Pharmacopoeia 
2007 for total aerobic count using plate count method. Pre-treated sample was inoculated 
on nutrient agar plates and were incubated for 96 hours and 120 hours at 34 ± 0.5 °C and 
22 ± 0.5 °C for bacteria and fungi respectively. Then the number of colony forming units 
was calculated for bacteria and fungi. 
Preparation of tablets 
Orodispersible tablets of ofloxacin microspheres were prepared using direct compression 
technique and locust bean gum as a superdisintegrant. The selected batches of 
microspheres were incorporated into tablet formulation. Criteria for selection of 
microspheres included there particle size, flow properties, encapsulation efficiency and 
taste masking ability. Microspheres equivalent to 100 mg ofloxacin were taken for each 
tablet composition (table 2). Avicel PH 101 was used as a directly compressible diluent. 
The directly compressible mixture were compressed using mutipunch tableting machine 
(AK Industries, India) fitted with 12.50 mm flat faced punch and die set possessing 50 ton 
compression force.  658  K. Malik, G. Arora, and I. Singh:   
Sci Pharm. 2011; 79: 653–672 
Tab. 2.   Composition of orodispersible tablet formulations 
Ingredients (mg)  K1  K2  K3  K4 
Microspheres containing Ofloxacin equivalent to  100  100  100  100 
Locust bean gum  15  30  45  60 
Avicel PH 101  73  58  43  28 
Talc  6  6  6  6 
Magnesium stearate  6  6  6  6 
Total weight  600  600  600  600 
 
Evaluation of tablets 
Diameter and thickness 
A calibrated vernier calliper (Indian calliper industries, Ambala, India) was used to evaluate 
diameter and thickness of tablets. 
Hardness 
The hardness of the tablets was determined by using Monsanto hardness tester (Pharma 
Chem Machineries, Mumbai, India). A tablet hardness of about 4‐5 kg/cm
2 is considered 
adequate for mechanical stability.  
Friability 
As per USP 30-NF 25, twenty six tablets were taken which corresponded to 6.5 g weight. 
The tablets were placed in a Roche friabilator (EI Products, India) and were rotated at 25 
rpm for 4 minutes. The tablets were taken out, dedusted and reweighed. The percentage 
friability of the tablets was calculated by the formula, 
Percentage friability = 
Initial weight – Final weight
Initial weight 
 × 100 
Tablet tensile strength  
The tablet tensile strength is the force required to break a tablet by compressing it in the 
radial direction. It is measured using a vernier calliper and monsanto hardness tester. For 
measuring the hardness of the tablets, the plunger of the hardness tester is driven down at 
a speed of 20 mm/min. Tensile strength for crushing (T) is calculated using equation: 
T = 
2F
πdt
 × 100 
Where F is the crushing load, and d and t signify the diameter and thickness of the tablet, 
respectively. 
Weight variation test 
20 tablets from each batch were subjected to weight variation test. As per Indian 
Pharmacopoeia standards, the tablets should be within the specified limits i.e. ± 5% of 
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Wetting Time  
A piece of tissue paper (10.75×12 mm) folded twice was placed in a culture dish (d=6.5 
cm) containing 6 ml of simulated saliva (phosphate buffer pH 6.8). A tablet was carefully 
placed on the surface of tissue paper and the time required for simulated saliva to reach 
the upper surface of the tablet was noted as the wetting time [24]. 
Water Absorption Ratio  
Test was done with the same procedure as that of wetting time. In this test initial weight of 
tablet was noted before placing on petri dish. After complete wetting the wetted tablet was 
then weighed. Water absorption ratio, R was determined using the equation, 
R = 
Wa − Wb
Wb
×100 
Where, Wa is weight of tablet after water absorption and Wb is weight of tablet before 
absorption [24]. 
Effective pore radius (Reff.P) 
Reff.P of the powder blend was evaluated by method reported by Rana et al [25]. In this 
method a micropipette tip (2ml, transparent) was completely filled with powder and 
weighed (Wi). Then n-hexane (surface tension (γ) 18.4 mN/m) was poured dropwise on 
bedtop till the solvent filtered out at the bottom of the tip. The tip was reweighed (Wf). 
Effective pore radius was the calculated from the following formula. The experiments were 
repeated 3 times. 
Reff.P=
Wf − Wi
2πγ
 
Porosity  
Porosity is a measure of the void spaces in a material, and is a fraction of the volume of 
voids over the total volume, between 0–1, or as a percentage between 0–100.  
The porosity of the tablets was calculated as follows: 
ϵ = 1 −
m
ρtrue×V
 
Where ρ true is the true density of the mixture, m and V are the weight and volume of the 
tablet, respectively. The true density of the powder was found using true density meter 
(SMART PYCNO 30, Maharashtra, India). In order to calculate true density, two pressure 
readings were taken. Initially helium gas was pressurised in a known reference volume 
and this reading was taken as first pressure reading. Then the gas is allowed to pass to 
sample cell containing the sample material due to which there is a drop in pressure as 
compared to initial pressure and this dropped pressure is taken as second pressure 
reading. Then material volume is calculated from which true density is calculated. When 
Helium is used initially vacuum is necessary to remove air from the pores of the sample. 
After that purging with Helium gas is done. Then the normal procedure is followed. 660  K. Malik, G. Arora, and I. Singh:   
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Tablet packing fraction 
The tablet packing fraction (Pf) is a measure of the degree of consolidation or 
compactness of the tablet. Tablet packing fraction was determined by: 
Packing fraction (Pf) = 
w
π r2 t ρ
 
Where w is the weight of a tablet, r is radius, t is thickness and ρ is the particle density. 
Ten tablets were used in each measurement. The radius and thickness of tablets were 
measured using a vernier calliper. The apparent particle density of the drug powder was 
determined using liquid paraffin displacement method. Firstly, the weight of a specific 
gravity bottle filled with liquid paraffin and the weight of the specific gravity bottle 
containing a sample of the drug powder (1000 mg) was noted and then it was filled with 
liquid paraffin after which the final weight was determined. The determination was 
performed in triplicate, and mean results were used in the calculation of Pf. If the packing 
fraction is very high, fluid is unable to penetrate in the tablet which leads to slower 
disintegration [26]. 
In-vitro disintegration time 
Disintegration time for orodispersible tablets was determined using USP disintegration 
apparatus (EI Products, Panchkula, India) with 0.1 N Hcl (900 ml at 37±1 °C) as the 
disintegrating medium. To comply with the test all of the tablets should disintegrate within 
3 minutes as per official requirements as given in European Pharmacopoeia 2001. 
In-vivo disintegration time [25] 
A protocol for conducting disintegration time assessment was accepted by the Institutional 
Ethical Committee of Chitkara University. In vivo disintegration time was judged in five 
healthy male volunteers for each batch of tablets. The volunteers were previously well-
versed for purpose of the study. Prior to the test the volunteers were instructed to rinse 
their oral cavity with distilled water. Each volunteer was asked to place one tablet on the 
tongue. Volunteers were strictly told not to chew or swallow the tablets, though licking was 
allowed. The end point for disintegration was taken when there was no lump left in the oral 
cavity. After the test was finished, volunteers were told to rinse there mouth properly.  
Moisture uptake studies 
Due to high content of hydrophilic excipients, orodispersible tablets have increased chance 
of moisture uptake which greatly affects stability of moisture sensitive products, so there is 
a need for special attention towards storage and packaging of orodispersible tablets. 
Therefore, moisture uptake studies are strongly recommended for orodispersible tablets 
[27]. The test was performed by keeping ten tablets in a desiccator (containing calcium 
chloride) for 24 hours at 37 °C to assure complete drying. The tablets were then weighed 
and stored for 2 weeks at 75% humidity. To achieve this humidity conditions, a saturated 
solution of sodium chloride was kept at the bottom of the desiccator for three days. On the 
tenth day tablets were re-weighed and the percentage increase in tablet weight was 
recorded.   Taste Masked Microspheres of Ofloxacin: Formulation and Evaluation of Orodispersible Tablets  661 
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In-vitro dissolution Studies 
In vitro drug release of the prepared batches was determined using eight stage USP 
dissolution apparatus II (Lab India, DS 8000, Mumbai, India). The dissolution test was 
performed using 900 ml of 0.1 N Hcl buffer at 37 ± 0.5 ºC. The speed of rotation of paddle 
was set at 50 rpm. At a predetermined time interval, 5 ml samples were withdrawn, filtered 
through whatman filter paper, amply diluted and analysed at absorption maxima of 294nm 
according to Indian Pharmacopoeia 2007 using UV-Visible spectrophotometer (Systronics 
2202, Ahmedabad, India). The in-vitro dissolution studies were performed in triplicate. 
Stability testing 
The prepared batches were evaluated for stability studies. During the full duration of study 
temperature and relative humidity of about 40 ± 2 °C  and 75% RH respectively were 
maintained. The formulations were analysed at 0 day, 1 and 3 month time interval for 
hardness, friability, taste evaluation score, drug content and in-vitro disintegration time. 
Results and Discussions 
Evaluation of microspheres 
Tab. 3.   Microsphere evaluation parameters 
Batch  Ofloxacin 
(Drug)  
(in mg) 
Eudragit 
(Polymer) 
(in mg) 
D:P  
Ratio 
Stirring  
Speed 
% Yield 
± S.D.*
 
Entrapment 
Efficiency 
(%) ± S.D.
* 
Taste 
masking 
score 
A1  100  100  1:1  400  89.52  
± 0.52 
73.41  
± 1.26  3 
A2  100  100  1:1  800  92.41  
± 0.26 
72.56 
± 2.51  3 
A3  100  100  1:1  1200  93.64  
± 0.45 
69.54 
± 1.98  3 
B1  100  200  1:2  400  91.52  
± 0.78 
81.25 
± 1.58  2 
B2  100  200  1:2  800  88.61  80.52 
± 1.38  2 
B3  100  200  1:2  1200  92.44  78.93 
± 1.14  2 
C1  100  400  1:4  400  97.21  
± 0.41 
84.93 
± 1.65  1 
C2  100  400  1:4  800  94.56  83.33 
± 2.75  1 
C3  100  400  1:4  1200  92.06  80.01 
± 2.65  1 
D1  100  500  1:5  400  96.54  
± 0.45 
86.52 
± 2.25  1 
D2  100  500  1:5  800  95.42  85.97 
± 1.03  1 
D3  100  500  1:5  1200  96.33  
± 0.54 
84.93 
± 2.12  1 
* Values are mean ± SD (n=3) 662  K. Malik, G. Arora, and I. Singh:   
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Microspheres with different drug to polymer ratios were prepared using solvent 
evaporation technique. The prime parameters for selection of batches of microspheres for 
tableting were based on particle size, entrapment efficiency, flow characters and taste 
masking evaluation. 
Percentage yield and Entrapment Efficiency 
Percentage yield and entrapment efficiency were determined for the prepared batches of 
taste masked ofloxacin microspheres (table 3). Percentage yield obtained varied from 
88.61 ± 0.52 to 96.33 ± 0.45. Entrapment efficiency increased with increase in polymer 
ratio but decreased with increase in stirring speed as the size of the microspheres reduced 
which resulted in decrease in entrapment efficiency (table 3).  
Evaluation of flow properties 
The prepared batches of microspheres were evaluated for bulk density, tapped density, 
angle of repose, carr’s consolidation index and hausner ratio. The results of powder flow 
properties (table 4) clearly indicate good flow characteristics for batches having drug to 
polymer ratio 1:4 and 1:5.  
Tab. 4.   Microsphere powder flow properties 
Parameters  Results 
A1  A2  A3  B1  B2  B3 
Bulk Density(g/cm
3)  0.60  
± 0.02 
0.60  
± 0.15 
0.58  
± 0.05 
0.56  
± 0.12 
0.58  
± 0.05 
0.55  
± 0.09 
Tapped density(g/cm
3)  0.59  
± 0.12 
0.58  
± 0.03 
0.54  
± 0.04 
0.50  
± 0.02 
0.51  
± 0.08 
0.45  
± 0.06 
Carr’s compressibility 
index (%) 
38.33  
± 0.55 
36.66  
± 0.19 
35.11  
± 0.22 
33.28  
± 0.44 
29.93  
± 0.67 
26.81  
± 0.23 
Angle of Repose  42.23  
± 0.11 
40.52  
± 0.23 
39.12 
± 0.25 
37.56  
± 0.34 
35.22  
± 0.45 
31.21  
± 0.23 
Hausner Ratio  1.01  
± 0.02 
1.03  
± 0.01 
1.07  
± 0.04 
1.12  
± 0.02 
1.13  
± 0.01 
1.22  
± 0.05 
Parameters 
Results 
C1  C2  C3  D1  D2  D3 
Bulk Density(g/cm
3)  0.58  
± 0.03 
0.59  
± 0.01 
0.61 
± 0.03 
0.55  
± 0.11 
0.59  
± 0.04 
0.57  
± 0.04 
Tapped density(g/cm
3)  0.46  
± 0.05 
0.47  
± 0.02 
0.50  
± 0.01 
0.43  
± 0.12 
0.47  
± 0.22 
0.45  
± 0.15 
Carr’s compressibility 
index (%) 
21.31  
± 0.21 
20.66  
± 0.12 
20.96  
± 0.23 
23.18  
± 0.66 
20.66  
± 0.57 
21.94  
± 0.78 
Angle of Repose  28.12  
± 0.56 
28.05  
± 0.12 
27.89  
± 0.23 
27.56  
± 0.12 
27.23  
± 0.67 
27.05  
± 0.11 
Hausner Ratio  1.26  
± 0.05 
1.25  
± 0.01 
1.22  
± 0.06 
1.28  
± 0.02 
1.25  
± 0.01 
1.26  
± 0.02 
 
   Taste Masked Microspheres of Ofloxacin: Formulation and Evaluation of Orodispersible Tablets  663 
Sci Pharm. 2011; 79: 653–672 
Particle size evaluation 
Size distribution and average particle size of microspheres was calculated with optical 
microscopy. Upon increase in stirring speed there was reduction in average particle size of 
microspheres. The mean diameter of the prepared batches of microspheres (C1-C3) was 
found to be 270.52 µm, 232.23 µm and 205.54 µm respectively. Particle size distribution of 
microspheres is represented by various histograms (Figures 1–3). 
 
Fig. 1.   Histogram depicting particle size distribution of prepared microspheres at 400 
rpm. 
 
  
Fig. 2.   Histogram depicting particle size distribution of prepared microspheres at 800 
rpm. 
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Fig. 3.   Histogram depicting particle size distribution of prepared microspheres at 1200 
rpm. 
Morphology 
The morphology of the prepared batches of microspheres was evaluated by scanning 
electron microscopy. Scanning electron micrographs are shown in figure 4 and 5. The 
micrographs of microspheres having drug and polymer ratio as 1:1 showed uneven 
surface and that of 1:4 showed to have smooth surfaces and bigger size. So, polymer 
concentration along with stirring speed was required to be controlled to an optimum level.  
 
Fig. 4.   Scanning electron micrograph of microspheres (X100) having drug to polymer 
concentration 1:1   Taste Masked Microspheres of Ofloxacin: Formulation and Evaluation of Orodispersible Tablets  665 
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Fig. 5.   Scanning electron micrograph of microspheres (X1000) having drug to polymer 
concentration 1:4 
Chemical Interaction studies 
In order to check chemical interaction between drug and polymer, thermal analysis was 
carried out by using Differential Scanning Calorimetry. DSC thermograms of Ofloxacin, 
Eudragit E100 and the formulation showed that there were no changes in the endotherms 
(Figure 6). The drug exhibited a sharp melting endotherm in the core and coated 
formulation. 
  
Fig. 6.   DSC Thermograms of Ofloxacin, Eudragit E100 and microspheres 666  K. Malik, G. Arora, and I. Singh:   
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In-vitro taste evaluation of microspheres 
For evaluation of taste masking, drug release was studied in pH 6.8 phosphate buffer 
(simulated saliva). Microspheres with drug to polymer ratio 1:1 exhibited poorest taste 
masking and that of 1:4 and 1:5 showed excellent results for in-vitro taste masking.  
In-vivo taste evaluation of microspheres 
The prepared microspheres were subjected to taste evaluation test in 5 healthy male 
volunteers according to set protocol. The results of taste evaluation studies are shown in 
table 3. The microspheres having drug to polymer ratio 1:4 and 1:5 were found to be 
tasteless to most of the volunteers.  
Based upon % yield, entrapment efficiency, flow properties, morphology and taste masking 
properties, batch C1 was found to be optimum and was further selected for tableting. 
Characterization of locust bean gum 
Swelling index of 1% w/v solution of locust bean gum was found to be 2000 which 
indicated toward good swelling tendency of the natural gum. Loss on drying was obtained 
to be 13.53% which was well within limits for locust bean gum (max 14%). Viscosity of 1% 
w/v solution of locust bean gum using spindle number 62 of Brookfield viscometer at 37 ± 
1 °C was found to be 83, 81, 82.5, 80.4 and 78 at 5, 10, 20, 50 and 100 rpm respectively. 
pH of 1% w/v solution at 37 ± 1 °C was found to be 5.79.  
As natural materials are prone to possess microbial contamination so it becomes 
necessary to perform microbial load studies. Total aerobic count using plate count method 
was determined as given in Indian Pharmacopoeia 2007. The number of colony forming 
units were found to be 99 CFUs/g and 13 CFUs/g for bacteria and fungi respectively which 
were well within limits as per Indian Pharmacopoeia 2007 for total aerobic count.  
Tablet evaluation 
All the batches of orodispersible tablets were formulated under similar conditions to avoid 
processing variables. The tablets prepared by direct compression method were found to 
be free from capping, chipping and sticking. The prepared tablets were evaluated for 
various physical parametric tests (table 5). An appreciable effect was seen on tablet 
hardness, friability and tensile strength due to increasing concentration of locust bean gum 
(figure 7). All of the batches passes weight variation test. Wetting time, water absorption 
ratio and in-vitro disintegration time were found to be ranging between 19 ± 2 to 10 ± 3 
seconds, 59.11 ± 0.65 to 85.76 ± 0.96 and 22 ± 2 to 10 ± 2 second respectively. Reff.P is an 
indicator of tablet porosity. Reff.P and porosity (figure 8 and 9) were found to be ranging 
from 3.452 ± 0.15 to 3.992 ± 0.86 mm and 15.006% to 23.547 % respectively indicating 
appreciable capability of locust bean gum to increase water penetration due to wicking 
action which increases porosity thus lowers disintegration time with increase in polymer 
concentration. The tablet packing fraction (Pf) is a measure of the degree of consolidation 
or compactness of the tablet. Tablet packing fraction was found to be 0.843, 0.822, 0.802 
and 0.764 (K1–K4) which indicated towards good porosity imparting character of the 
natural polymer. The in-vivo disintegration time was found to be 22 ± 2 to 10 ± 2 seconds 
(K1–K4). In vivo performance of the formulated orodispersible tablets using locust bean 
gum as superdisintegrant was well in line with the in vitro results.   Taste Masked Microspheres of Ofloxacin: Formulation and Evaluation of Orodispersible Tablets  667 
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Tab. 5.   Evaluation of prepared tablets 
Parameters  K1  K2  K3  K4 
Diameter (mm)  12.50 ± 0.05  12.51 ± 0.03  12.50 ± 0.02  12.50 ± 0.04 
Thickness (mm)  4.71 ± 0.03  4.75 ± 0.04  4.73 ± 0.02  4.78 ± 0.04 
Friability (%)  0.59 ± 0.04  0.48 ± 0.05  0.38 ± 0.01  0.24 ± 0.03 
Hardness (kg/cm
2)  2.84 ± 0.54  3.80 ± 0.23  4.95 ± 0.55  6.01 ± 0.75 
Tensile strength (MN/m
2)  0.468 ± 0.15  0.684 ± 0.12  1.02 ± 0.05  1.198 ± 0.10 
Weight variation test  Pass  Pass  Pass  Pass 
Wetting time (sec)  19 ± 2  16 ± 1  14 ± 2  10 ± 3 
Water absorption ratio %  59.11 ± 0.65  69.95 ± 0.84  76.45 ± 0.78  85.76 ± 0.96 
In-vitro disintegr. time (sec)  20 ± 1  15 ± 2  14 ± 2  12 ± 1 
In-vivo disintegr. time (sec)  22 ± 2  17 ± 3  13 ± 1  10 ± 2 
Moisture uptake (%)  0.71 ± 0.13  0.75 ± 0.25  0.82 ± 0.19  0.84 ± 0.26 
 
  
Fig. 7.   Effect of locust bean concentration on tablet hardness and friability. 
  
Fig. 8.   Effect of locust bean gum on effective pore radius 
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Fig. 9.   Effect of locust bean gum on tablet porosity. 
In vitro ofloxacin release was 97.25% (K1), 99.55% (K4) for the prepared batches of 
orodispersible tablets (figure 10). 
  
Fig. 10.   Dissolution profile of prepared orodispersible tablets containing taste masked 
ofloxacin microspheres. 
Stability studies for the prepared batches containing locust bean gum as superdisintegrant 
was performed which indicated that there was no significant change in tablet hardness, 
friability, taste evaluation score, drug content and in-vitro disintegration time (table 6). 
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Tab. 6.   Stability study data of orodispersible tablets 
  Parameter (Months) 
 
Hardness  Friability  Taste evaluation  
score 
Batch  0  1  3  0  1  3  0  1  3 
K1  2.84  
± 0.54 
2.71  
± 0.12 
2.52  
± 0.80 
0.59  
± 0.04 
0.62  
± 0.09 
0.65  
± 0.05 
1  1  2 
K2  3.80  
± 0.23 
3.52  
± 0.30 
3.27  
± 0.10 
0.48  
± 0.05 
0.52 
± 0.04 
0.58 
± 0.12 
1  1  2 
K3  4.95  
± 0.55 
4.55  
± 0.35 
3.95 
± 0.22 
0.38  
± 0.10 
0.41 
± 0.05 
0.43 
± 0.06 
1  1  2 
K4  6.01  
± 0.75 
5.74  
± 0.34 
5.52 
± 0.55 
0.24  
± 0.01 
0.27 
± 0.04 
0.33 
± 0.05 
1  1  2 
  Parameter (Months)       
  Drug content  In-vitro disintegration 
time 
     
Batch  0  1  3  0  1  3       
K1  99.24  
± 0.25 
98.50 
± 0.10 
97.54 
± 0.25 
20 ± 1  21 ± 2  23 ± 3       
K2  98.45 
± 0.66 
98.44  
± 0.55 
98.66 
± 0.85 
15 ± 1  17 ± 2  19 ±1       
K3  98.98 
± 0.15 
97.23  
± 0.50 
96.56 
± 0.35 
14 ± 2  15 ± 1  17 ± 2       
K4  97.12 
± 0.66 
96.85 
± 0.33 
96.52 
± 0.14 
12 ± 2  13 ± 1  15 ± 1       
 
Conclusions 
The purpose of the present study was to develop taste masked microspheres of ofloxacin 
using Eudragit E100 employing solvent evaporation technique as method of preparation of 
microspheres. The formulated microspheres were incorporated into tablet dosage form 
using locust bean gum as natural tablet superdisintegrant. In conclusion eudragit polymers 
have excellent taste masking potential and natural excipients could prospectively be used 
as nutraceuticals for their pharmaceutical applications.  
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